Table 3 Clinical characteristics of patients with GUTB
Clinical characteristics | No. of patients (%) (n = 112) |
|---|---|
Gender | |
 M | 52 (46.43%) |
 F | 60 (53.57%) |
Age | |
 0 months–1 year | 1 (0.89%) |
 1 year–5 years | 2 (1.79%) |
 6 years–10 years | 4 (3.57%) |
 11 years–18 years | 18 (16.07%) |
 19 years–29 years | 21 (18.75%) |
 30 years–49 years | 35 (31.25%) |
 50 years–69 years | 27 (24.11%) |
 70 years or older | 4 (3.57%) |
Marital status | |
 Single/widowed | 69 (61.61%) |
 Married | 43 (38.39%) |
Occupation | |
 Employed | 19 (16.96%) |
 Unemployed | 58 (51.79%) |
 Not applicable (i.e., pediatric) | 26 (23.21%) |
 Unspecified | 9 (8.04%) |
Location | |
 Urban | 60 (53.57%) |
 Rural | 48 (42.86%) |
 Unspecified | 4 (3.57%) |
Co-morbidity | |
Previous TB | 14 (12.50%) |
Diabetes mellitus | 5 (4.46%) |
HIV/AIDS | 12 (10.71%) |
Steroid use (e.g., SLE, NS) | 9 (8.04%) |
Malignancy | 1 (0.89%) |
Chronic kidney disease | 5 (4.46%) |
History of urolithiasis | 8 (7.14%) |
RTA Type 1 | 1 (0.89%) |
COPD | 2 (1.79%) |
Bronchial asthma | 2 (1.79%) |
Hypertension | 13 (11.61%) |
Heart failure | 2 (1.79%) |
Cerebrovascular disease | 1 (0.89%) |
Other organ involvement | 64 (57.14%) |
Pulmonary | 57 (50.89%) |
Gastrointestinal | 28 (25.00%) |
Abdominopelvic | 11 (9.82%) |
Central nervous system | 7 (6.25%) |
Bone | 4 (3.57%) |
Lymph node | 8 (7.14%) |
Ear | 2 (1.79%) |
Psoas | 2 (1.79%) |
Cutaneous/wound | 3 (2.68%) |
Chief complaint | |
Weakness | 16 (14.29%) |
Difficulty of breathing | 14 (12.50%) |
Flank pain | 13 (11.61%) |
Abdominal pain | 11 (9.82%) |
Hematuria | 9 (8.04%) |
Dysuria | 9 (8.04%) |
Fever | 8 (7.14%) |
Abdominal/pelvic mass on diagnostic | 5 (4.46%) |
Pedal edema | 4 (3.57%) |
Umbilical discharge | 3 (2.68%) |
Gluteal pain | 2 (1.79%) |
Vaginal bleeding | 2 (1.79%) |
Cough | 2 (1.79%) |
Seizure | 2 (1.79%) |
Urinary retention | 1 (0.89%) |
Inguinal pain | 1 (0.89%) |
Fistula formation (ureterocutaneous) | 1 (0.89%) |
Scrotal discharge | 1 (0.89%) |
Double J stent reinsertion | 1 (0.89%) |
Decrease in sensorium | 1 (0.89%) |
Vomiting | 1 (0.89%) |
Others | 5 (4.46%) |